SEC EDGARSEP 141 min read$PATH

Gupta Ashim sold $1.6M of PATH

Gupta Ashim (COO) sold 117,339 shares of UiPath, Inc. (PATH) at $13.85 ($1.63M total) on 2026-09-11 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · Gupta Ashim

Published Sep 14, 2026, 8:29 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 14, 2026, 9:22 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$PATH

Neutral

medium confidence

Mentioned

$PATH

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$PATHNeutralLow

Why it matters

The insider sale is a primary source event but modest in scale, offering limited trading impetus.

Market read

A small insider sell by a C‑suite officer; unlikely to move the stock materially.

What to watch

Potential upcoming corporate actions or compensation plans not disclosed.

Relevance 5/10Novelty 5/10Timing: post‑market filing on 2026‑09‑14

Background

SEC Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$PATHNeutralMedium confidence

Context

COO Ashim Gupta sold 117,339 PATH shares for $1.6M via a 10b5‑1 plan on 2026‑09‑11.

Expected impact

Minimal short‑term price pressure; likely absorbed without significant move.

Evidence & confidence

The sale size (~$1.6M) is small relative to UiPath's market cap; insider C‑suite sales can be a mild bearish signal but are not decisive.

Market effects

Sector

Limited impact on the broader RPA/software sector.

Regional

No notable regional effect; UiPath trades primarily on US exchanges.

Global

Insignificant for global markets.

Counterpoint

What could challenge this read

The sale could be routine liquidity planning; investors may ignore it.

Key entities

Company
UiPath, Inc.
Provider of robotic process automation software, ticker PATH.
Executive
Ashim Gupta
Chief Operating Officer of UiPath.

Read at source ← All news

SEP 17

$PATHMed

A Philippine Telecom’s AI Makeover Tests UiPath’s (PATH) Pitch

UiPath (PATH) announced that PLDT, a Philippine telecom, scaled its use of UiPath's AI platform, improving efficiency and saving thousands of work hours. PATH reported Q2 2027 revenue of $410M, up 13% YoY, and annual recurring revenue of $1.938B, up 12%. The company also introduced new products and reshuffled its executive team. PATH's net new ARR was $37M, and GAAP operating income was $32M, below non-GAAP figures.

insidermonkey.com3 min

SEP 14

$PATHHigh

UiPath (PATH) Stock: Jump as Gartner Recognizes IDP Leadership

UiPath (PATH) stock rose 7.53% to $14.78 after Gartner named it a Leader in Intelligent Document Processing for the second year. The recognition highlights UiPath's role in enterprise automation and document management, with its IXP platform converting complex documents into structured data for workflows.

blockonomi.com2 min

SEP 13

$AIMedAI 8/10

C3.ai vs. UiPath: What Revenue Trends Between These Artificial Intelligence Companies Tell Investors

C3.ai (AI) reported a -188% operating margin for Q2 2026, despite restructuring and new agreements, while UiPath (PATH) reported an 8% margin. C3.ai's revenue declined, but customer bookings rose 73% QoQ. UiPath's revenue grew 13% YoY in Q2 but expects slower growth in Q3.

fool.com3 min

SEP 13

$PATHHighAI 8/10

UiPath, Inc. (PATH) Stock Has AI Potential, But Slowing Growth Keeps Investors Cautious

UiPath (NYSE:PATH) shares are down year-to-date, but Wall Street sentiment is improving. DA Davidson raised its price target to $16. Q2 revenue grew 13% YoY to $410M, with ARR up 12%. Q3 guidance is $440M-$445M. Hedge funds increased stakes, but short interest is high at 29%. Growth concerns persist due to AI competition and monetization uncertainties.

insidermonkey.com3 min

SEP 11

$PATHMedAI 8/10

UiPath Stock Rises 2.2%—Why Its 89% AI Survey Result Isn’t Revenue Yet

UiPath (PATH) shares rose 2.21% to $13.87 on Thursday, though still down 23.9% from pre-earnings levels. A company-sponsored survey showed 89% of respondents with embedded orchestration met ROI expectations, but this doesn't guarantee revenue growth. Q2 revenue increased 13% to $410M, with ARR up 12% to $1.938B. Management expects Q3 ARR of $1.992B-$1.997B. Investors await evidence of monetization at Investor Day on September 22.

ts2.tech2 min

SEP 10